Page 90 - GPD-2-3
P. 90

Gene & Protein in Disease                                         MIS-A with LETM after SARS-CoV-2 vaccine




            Table 1. Results of preliminary investigation
                                      December 27, 2021  December 28, 2021;   December 28, 2021;   December 29, 2021
                                                      morning            evening
            Hemoglobin (mmol/L)       1.61            1.49               1.63              1.64
            Total leukocyte count (/L)  11.01×10 9    13.7×10 9          19.9×10 9         18.9×10 9
            Differential leukocyte count  P73L20%     P95L3.5%           P95L5%,           P93L4%
            Platelets (/L)            176×10 9        68×10 9            70×10 9           44×10 9
            Blood urea nitrogen (mmol/L)  5.71        /                  12.5              12.5
            Creatinine (μmol/L)       64.5            /                  348.3             384.5
            Total bilirubin/direct (μmol/L)  /        80.5/34.9          /                 122.8/74.9
            SGOT/SGPT (μKat/L)        0.4/0.33        2.09/0.9           7.02/3.32         7.6/3.39
            Sodium/potassium/calcium (mmol/L) 139/4.05/7.7  136/4.1/7.6  132/3.6/7.5       139/3.9/7.7
            PT/APTT/INR (s)           /               /                  22.7 (13.6)/70 (33)/1.71  34.3 (13.6)/79.8 (33)/2.64
            D dimer/Fib               /               /                  /                 >Max/-
            Peripheral blood smear    /               /                  Normocytic macrocytes,  /
                                                                         schistocytes and
                                                                         no toxic granules
            Urine routine and culture  /              Normal/no growth   /                 /
            Blood culture             /               No growth          /                 /
            Miscellaneous             •  Serum porphyrins:   • U1‑nRNP/Sm: negative  • CSF‑Cells‑02  •  Spot urine protein: 495
                                       negative       • Sm: negative     •  Glucose (CSF/serum):   mg/dl
                                      • CPK: normal   • SS‑A: negative    1.14/2.56 mmol/L  • ABG: respiratory alkalosis
                                      • ABG: normal   • Ro‑52: negative  • Protein: 1050 mg/L,  • CPK: 316 U/L
                                      •  Thyroid function test:  • SS‑B/La: negative  • Stains: negative  • CPK‑MB: 0.43 μKat/L
                                       normal         • Scl‑70: negative  •  COVID antibody   •  Dengue/malaria/typhoid/
                                      •  RT‑PCR for   • Pm‑Scl: negative  (total): 2816 IU/mL   leptospira/scrub typhus/
                                       SARS‑CoV‑2: negative • Jo‑1: negative  (normal<1000 IU/mL)  lyme: negative
                                                      • CENP‑B: negative                   •  NT‑ProBNP: >8260
                                                      • PCNA: negative                      pmol/L
                                                      • dsDNA: negative                    • Procalcitonin: >200 ng/mL
                                                      • ANA (IF) : negative                • CRP: 1240 mg/L
                                                      • cANCA/pANCA: negative              •  HBsAg/Anti HCV/HIV/
                                                                                            VDRL: negative
                                                                                           • USG (W/A): normal
                                                                                           •  2D echocardiography:
                                                                                            global left ventricular
                                                                                            hypokinesia
                                                                                           • LVEF: 45%
            Note: /: Not done.  Abbreviations: ABG: Arterial blood gas; ANA: Antinuclear antibody; ANCA: Antineutrophilic cytoplasmic antibody; APTT:
            Partial thromboplastin time–activated; cANCA: ANCA that targets proteinase 3; CRP: C‑reactive protein; CSF: Cerebrospinal fluid; CPK: Creatine
            phosphokinase; dsDNA: Double‑stranded DNA; HBsAg: Hepatitis B surface antigen; HCV: Hepatitis C virus; HIV: Human immunodeficiency virus;
            INR: International normalized ratio; LVEF: Left ventricular ejection fraction; pANCA: ANCA that targets myeloperoxidase; PCNA: Proliferating cell
            nuclear antigen; PT: Prothrombin time; RT‑PCR: Reverse‑transcription polymerase chain reaction; SGOT: Serum glutamic‑oxaloacetic transaminase;
            SGPT: Serum glutamic‑pyruvic transaminase; USG (W/A): Ultrasonography of whole abdomen; VDRL: Venereal disease research laboratory test.

            dissociation. On the other hand, nerve conduction study   serum  neuromyelitis  optica  and  myelin  oligodendrocyte
            revealed pure motor involvement in both upper and lower   glycoprotein antibody.
            limbs, and magnetic resonance imaging (MRI) of the
            brain and spine performed on January 11, 2022, revealed   In view of less-than-satisfactory neurological recovery, she
            minimal sub-arachnoid hemorrhage in left Sylvian fissure   was further treated with pulse intravenous methylprednisolone
            and long segment altered signal intensity from C6 to conus   1 g for 5 days during January 15–19, 2022, followed by oral
            medullaris, which was suggestive of LETM. Figure 1 shows   prednisolone taper. Hemodialysis treatment was indicated
            an MRI image displaying LETM in cervico-dorsal cord.   for her for 1 month since she had anuric acute kidney injury,
            Further tests showed that the patient was negative for   and her renal functions improved gradually over 1 month.


            Volume 2 Issue 3 (2023)                         3                        https://doi.org/10.36922/gpd.1320
   85   86   87   88   89   90   91   92   93   94   95